Jerry P. Gilless, MD

Chronic Kidney Disease
Chronic Kidney Disease
Minimizing Risk of Mental Status Changes with H2 Blockers: Dosage Adjustments in Kidney Dysfunction
12/12/2014
Jerry P. Gilless, MD; Joanna Q. Hudson, PharmD, BCPS; Timothy H. Self, PharmD
For the past 35 years, histamine2 blockers (H2 blockers) have continued to have widespread use within the United States. Soon after cimetidine was released, central nervous system (CNS) reactions were...
12/12/2014
Chronic Kidney Disease
Chronic Kidney Disease
Minimizing Risk of Mental Status Changes with H2 Blockers: Dosage Adjustments in Kidney Dysfunction
12/12/2014
Jerry P. Gilless, MD; Joanna Q. Hudson, PharmD, BCPS; Timothy H. Self, PharmD
For the past 35 years, histamine2 blockers (H2 blockers) have continued to have widespread use within the United States. Soon after cimetidine was released, central nervous system (CNS) reactions were...
12/12/2014
Chronic Kidney Disease
Chronic Kidney Disease
Minimizing Risk of Mental Status Changes with H2 Blockers: Dosage Adjustments in Kidney Dysfunction
12/12/2014
Jerry P. Gilless, MD; Joanna Q. Hudson, PharmD, BCPS; Timothy H. Self, PharmD
For the past 35 years, histamine2 blockers (H2 blockers) have continued to have widespread use within the United States. Soon after cimetidine was released, central nervous system (CNS) reactions were...
12/12/2014